Management of Symptoms in Children With Autism Spectrum Disorders: A Comprehensive Review of Pharmacologic and Complementary-Alternative Medicine Treatments

被引:55
作者
Huffman, Lynne C. [1 ]
Sutcliffe, Trenna L. [2 ]
Tanner, Ima S. D. [3 ]
Feldman, Heidi M. [1 ]
机构
[1] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA
[2] Palo Alto Med Fdn, Dept Pediat, Los Altos, CA USA
[3] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA
关键词
autism; autism spectrum disorder; review; treatment; pharmacologic; complementary-alternative medicine; PERVASIVE DEVELOPMENTAL DISORDERS; PLACEBO-CONTROLLED CROSSOVER; SYNTHETIC HUMAN SECRETIN; LONG-TERM RISPERIDONE; OPEN-LABEL TRIAL; DOUBLE-BLIND; PORCINE SECRETIN; YOUNG-CHILDREN; RETROSPECTIVE ASSESSMENT; NALTREXONE TREATMENT;
D O I
10.1097/DBP.0b013e3182040acf
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
In the care of children with autism spectrum disorders (ASD), medical treatment is typically considered an adjunct to educational and behavioral interventions. Nonetheless, large proportions of children with ASD are managed medically and receive both pharmacologic and complementary-alternative medicine (CAM) treatments. Although many medical treatments have been studied in children with ASD, studies vary widely in terms of the sample, sample size, research design, purposes of treatment, and measurements of change. Surprisingly, comprehensive reviews of the options for medical management in ASD are lacking, particularly reviews that address both pharmacologic and CAM treatments. Furthermore, reviews to date tend to emphasize general effects of medication; this perspective contradicts medical practice, which targets particular symptoms during treatment selection and monitoring. This review of 115 studies adds to the ASD treatment literature by (1) including studies of individuals 0 to 22 years of age; (2) aggregating studies of pharmacologic treatments and CAM treatments; and importantly, (3) organizing treatment response by ASD symptoms, differentiating core and associated symptoms.
引用
收藏
页码:56 / 68
页数:13
相关论文
共 136 条
[1]  
Adams JB, 2004, J ALTERN COMPLEM MED, V10, P1033, DOI 10.1089/acm.2004.10.1033
[2]   Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial [J].
Akhondzadeh, S ;
Erfani, S ;
Mohammadi, MR ;
Tehrani-Doost, M ;
Amini, H ;
Gudarzi, SS ;
Yasamy, MT .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2004, 29 (02) :145-150
[3]  
Aman MG, 2005, ARCH GEN PSYCHIAT, V62, P1266
[4]   Acute and long-term safety and tolerability of risperidone in children with autism [J].
Aman, MG ;
Arnold, LE ;
McDougle, CJ ;
Vitiello, B ;
Scahill, L ;
Davies, M ;
McCracken, JT ;
Tierney, E ;
Nash, PL ;
Posey, DJ ;
Chuang, S ;
Martin, A ;
Shah, B ;
Gonzalez, NM ;
Swiezy, NB ;
Ritz, L ;
Koenig, K ;
McGough, J ;
Ghuman, JK ;
Lindsay, RL .
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2005, 15 (06) :869-884
[5]   Omega-3 fatty acids supplementation in children with autism:: A double-blind randomized, placebo-controlled pilot study [J].
Amminger, G. Paul ;
Berger, Gregor E. ;
Schaefer, Miriam R. ;
Klier, Claudia ;
Friedrich, Max H. ;
Feucht, Martha .
BIOLOGICAL PSYCHIATRY, 2007, 61 (04) :551-553
[6]   Effects of short- and long-term risperidone treatment on prolactin levels in children with autism [J].
Anderson, George M. ;
Scahill, Lawrence ;
McCracken, James T. ;
McDougle, Christopher J. ;
Aman, Michael G. ;
Tierney, Elaine ;
Arnold, L. Eugene ;
Martin, Andres ;
Katsovich, Liliya ;
Posey, David J. ;
Shah, Bhavik ;
Vitiello, Benedetto .
BIOLOGICAL PSYCHIATRY, 2007, 61 (04) :545-550
[7]  
[Anonymous], 2002, J. Neurother, DOI [DOI 10.1300/J184V06N04_05, 10.1300/J184v06n04_05]
[8]  
[Anonymous], 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890425787
[9]   Plasma amino acids profiles in children with autism: Potential risk of nutritional deficiencies [J].
Arnold, GL ;
Hyman, SL ;
Mooney, RA ;
Kirby, RS .
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2003, 33 (04) :449-454
[10]   Atomoxetine for hyperactivity in autism spectrum disorders: Placebo-controlled crossover pilot trial [J].
Arnold, L. Eugene ;
Aman, Michael G. ;
Cook, Amelia M. ;
Witwer, Andrea N. ;
Hall, Kristy L. ;
Thompson, Susan ;
Ramadan, Yaser .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2006, 45 (10) :1196-1205